Denali Therapeutics to Report Third Quarter 2026 Financial Results and Business Highlights on November 3, 2026
SOUTH SAN FRANCISCO, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI) today announced that it will report financial results and business highlights for the third quarter ended September 30, 2026, on Tuesday, November 3, 2026.
Covered in this story
Call it yourself
No calls on $DNLI yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Denali Therapeutics Inc →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.